{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:59:24Z","timestamp":1768013964158,"version":"3.49.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-18-IBS-082"],"award-info":[{"award-number":["1-18-IBS-082"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,7]]},"DOI":"10.1093\/cvr\/cvab226","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T19:25:02Z","timestamp":1625685902000},"page":"7-9","source":"Crossref","is-referenced-by-count":2,"title":["Prevention or therapy of the diabetic cardiomyopathy by fine O-GlcNAcylation balance: <i>hopes and concerns<\/i>"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3048-1135","authenticated-orcid":false,"given":"Lu","family":"Cai","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Radiation Oncology, Pharmacology and Toxicology, Pediatric Research Institute, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"2022031110194426300_cvab226-B1","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/S0021-9258(17)43295-9","article-title":"Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc","volume":"259","author":"Torres","year":"1984","journal-title":"J Biol Chem"},{"key":"2022031110194426300_cvab226-B2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41597-021-00810-4","article-title":"The human O-GlcNAcome database and meta-analysis","volume":"8","author":"Wulff-Fuentes","year":"2021","journal-title":"Sci Data"},{"key":"2022031110194426300_cvab226-B3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/BST20160164","article-title":"O-GlcNAcylation and cardiovascular disease","volume":"45","author":"Wright","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"2022031110194426300_cvab226-B4","article-title":"Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart","volume":"118","author":"Prakoso","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2022031110194426300_cvab226-B5","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.120.051911","article-title":"Excessive O-GlcNAcylation causes heart failure and sudden death","volume":"143","author":"Umapathi","year":"2021","journal-title":"Circulation"},{"key":"2022031110194426300_cvab226-B6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1042\/CS20170063","article-title":"Phosphoinositide 3-kinase (p110\u03b1) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction","volume":"131","author":"Prakoso","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"2022031110194426300_cvab226-B7","doi-asserted-by":"crossref","first-page":"H840","DOI":"10.1152\/ajpheart.00632.2019","article-title":"Gene therapy targeting cardiac phosphoinositide 3-kinase (p110\u03b1) attenuates cardiac remodeling in type 2 diabetes","volume":"318","author":"Prakoso","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031110194426300_cvab226-B8","doi-asserted-by":"crossref","first-page":"F1172","DOI":"10.1152\/ajprenal.00545.2015","article-title":"Role of O-linked N-acetylglucosamine modification in diabetic nephropathy","volume":"311","author":"Gellai","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031110194426300_cvab226-B9","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.febslet.2006.04.051","article-title":"Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1","volume":"580","author":"Gandy","year":"2006","journal-title":"FEBS Lett"},{"key":"2022031110194426300_cvab226-B10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/emm.2005.30","article-title":"O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes","volume":"37","author":"Park","year":"2005","journal-title":"Exp Mol Med"},{"key":"2022031110194426300_cvab226-B11","doi-asserted-by":"crossref","first-page":"e37427","DOI":"10.1371\/journal.pone.0037427","article-title":"Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvab226\/39608722\/cvab226.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/1\/7\/42828952\/cvab226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/1\/7\/42828952\/cvab226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T10:20:03Z","timestamp":1646994003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/118\/1\/7\/6319720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,7,12]]},"published-print":{"date-parts":[[2022,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvab226","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,7,12]]}}}